Generic Name: Daclizumab beta
Brand Name: Zinbryta
Manufacturer: Biogen Canada Inc.
Therapeutic Area: Multiple Sclerosis, relapsing-remitting
Indications: Multiple Sclerosis, relapsing
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: June 20, 2017
Recommendation Type: Reimburse with clinical criteria and/or conditions